The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stocks•7 April 2026•

1 min read

Qualifacts Acquires MethodOne to Strengthen Behavioral Health EHR Solutions

Key Facts

1Qualifacts acquired MethodOne to integrate Medication-Assisted Treatment (MAT) into its EHR platforms.

2The acquisition aims to enable Substance Use Disorder (SUD) providers to manage medication dispensing, clinical workflows, and billing in a unified solution.

Qualifacts has announced the acquisition of MethodOne, a move designed to integrate medication-assisted treatment (MAT) capabilities into its electronic health record (EHR) platforms. This strategic acquisition aims to provide a unified solution for healthcare providers specializing in substance use disorders (SUD) and opioid treatment programs. By incorporating MethodOne’s technology, Qualifacts will enable clinicians to manage medication dispensing, clinical workflows, and billing within a single, integrated interface. The integration is expected to streamline operations for healthcare providers, reducing administrative burdens and improving the overall delivery of patient care. While the entities involved are private, the deal underscores the growing consolidation and technological advancement within the niche behavioral health IT sector. This expansion solidifies Qualifacts' position as a leading provider of specialized healthcare technology solutions in an increasingly complex regulatory environment.